Friday, 24 May 2024

JLABS collaborates with EDB to transform Singapore’s Life Science Innovation Ecosystem

26 September 2023 | Company results

First-of-its-kind collaboration will integrate J&J Innovation - Johnson & Johnson Innovation into Singapore's life science ecosystem to accelerate regional innovation.

Johnson & Johnson International (Singapore) Pte. Ltd. has collaborated with the Singapore Economic Development Board (EDB) to unlock innovation potential in Singapore’s life sciences ecosystem. This collaboration is the first of its kind and will leverage Johnson & Johnson Innovation – JLABS’ services and innovation resources aimed at boosting the region’s innovation output.

Under this collaboration, JLABS will support early-stage companies with a base in Singapore to help accelerate their early-stage discoveries into innovative medicines, medical technologies, and healthcare solutions. JLABS will also collaborate with local incubators and other strategic partners in the ecosystem on venture and talent development offerings to stimulate employment and commercialization opportunities for early-stage companies.

This collaboration with EDB demonstrates the ongoing commitment of Johnson & Johnson to enable and accelerate the best science and technology in the Asia Pacific region with the ambition of addressing critical unmet medical and healthcare needs. It builds on the success of JLABS’ no-strings-approach and more than a decade of experience, as well as JLABS’ reputation as the largest global network of life science startups, investors, and corporate partners.

“At Johnson & Johnson Innovation, we source and cultivate the world’s most promising, early-stage healthcare innovation wherever it originates,” said William N. Hait, M.D., Ph.D., Executive Vice President, Chief External Innovation and Medical Officer, Johnson & Johnson. 

Melinda Richter, Global Head of Johnson & Johnson Innovation – JLABS said “this collaboration exemplifies our pivotal role as an innovation, talent, economic and venture developer with a mission to empower our partners with the knowledge, experience, networks and practical frameworks they need to make an impact for patients.”

Johnson & Johnson Innovation – JLABS and EDB will be co-hosting a symposium in Singapore before the end of the year, with subsequent announcements emerging from this new collaboration.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account